Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

NCT01169337 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

226

Enrollment

NIH

Sponsor class

Conditions

Light Chain Deposition Disease
Smoldering Multiple Myeloma

Interventions

OTHER: Clinical Observation
DRUG: Lenalidomide
OTHER: Quality-of-Life Assessment

Sponsor

National Cancer Institute (NCI)